You must have heard of pacemakers? They are required when the heart's natural system malfunctions, causing it to beat too ...

An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...

Heart disease claims 28.6 lakh lives annually in India, yet access to timely treatment remains severely inadequate, ...

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Express ...

Council land being donated for second diagnostics centre ...

“The Leader will cease publishing in February 2026,” read the bold headline across the top of the February 26, 2025, issue.

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in clinical studies were 2x more likely to convert sympto ...

Aster RV Hospital, Bengaluru Aster RV Hospital has successfully performed a rare and first-of-its-kind leadless pacemaker ...

So, WHOOP One. It’s this new membership thing from WHOOP, and the big question is whether it’s the best fitness tracker ...

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results ...